4//SEC Filing
Reape Kathleen 4
Accession 0001209191-23-039732
CIK 0001806310other
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 4:50 PM ET
Size
5.4 KB
Accession
0001209191-23-039732
Insider Transaction Report
Form 4
Reape Kathleen
Director
Transactions
- Award
Stock Option (right to buy)
2023-06-22+36,200→ 36,200 totalExercise: $0.72Exp: 2033-06-22→ Common Stock (36,200 underlying)
Footnotes (1)
- [F1]The shares vest on the earlier of June 22, 2024 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date.
Documents
Issuer
Taysha Gene Therapies, Inc.
CIK 0001806310
Entity typeother
Related Parties
1- filerCIK 0001832203
Filing Metadata
- Form type
- 4
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 4:50 PM ET
- Size
- 5.4 KB